{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-044220","form_type":"8-K","ticker":"OGEN","cik":"0001174940","company_name":"ORAGENICS INC","filed_at":"2023-12-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.418196+00:00","generated_at":"2026-06-07T15:26:37.069188+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Oragenics designates 8M Series F Convertible Preferred Stock for Odyssey asset purchase","bullets":["Filed Certificate of Designation for 8,000,000 shares of Series F Convertible Preferred Stock for the Odyssey Health asset purchase.","Series F is economically equivalent to common stock; liquidation junior to Class A, B, and Series E Preferred; no dividends, no voting rights.","Converts 1:1 into common stock upon close of Odyssey purchase, subject to shareholder approval for issuance and 350M authorized share increase.","Conversion capped at 19.9% of outstanding common stock until NYSE American listing or delisting and change-of-control approval if needed.","Redemption not permitted; no trading market expected; preemptive rights not provided."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-044220","json":"https://secwatch.observer/filing/0001493152-23-044220.json","markdown":"https://secwatch.observer/filing/0001493152-23-044220.md","text":"https://secwatch.observer/filing/0001493152-23-044220.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1174940/000149315223044220/0001493152-23-044220-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1174940/000149315223044220/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T15:26:37.069188+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"854a7462dda595d7f3e906fa5f638761da77d48c","claim":"ORAGENICS INC: Filed Certificate of Designation establishing Series F Convertible Preferred Stock (effective 2023-12-04).","evidence_excerpt":"On December 4, 2023, in anticipation of the the Odyssey Asset Purchase, the Company filed a Certificate of Designation with the Secretary of State for the State of Florida (the “ Certificate of Designation ”) designating 8,000,000 shares out of the authorized but unissued shares of its preferred stock as Series F Convertible Preferred Stock.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315223044220/0001493152-23-044220-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-12-04"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}